We are live on ! Find out more
JNJ icon

Johnson & Johnson

4,108 hedge funds and large institutions have $257B invested in Johnson & Johnson in 2024 Q4 according to their latest regulatory filings, with 471 funds opening new positions, 1,352 increasing their positions, 1,937 reducing their positions, and 177 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more first-time investments, than exits

New positions opened: 471 | Existing positions closed: 177

25% more call options, than puts

Call options by funds: $2.65B | Put options by funds: $2.11B

6% more funds holding

Funds holding: 3,8854,108 (+223)

0.54% more ownership

Funds ownership: 71.49%72.03% (+0.54%)

8% less capital invested

Capital invested by funds: $278B → $257B (-$20.9B)

24% less funds holding in top 10

Funds holding in top 10: 191146 (-45)

30% less repeat investments, than reductions

Existing positions increased: 1,352 | Existing positions reduced: 1,937

Holders
4,108
Holders Change
+223
Holders Change %
+5.74%
% of All Funds
54.07%
Holding in Top 10
146
Holding in Top 10 Change
-45
Holding in Top 10 Change %
-23.56%
% of All Funds
1.92%
New
471
Increased
1,352
Reduced
1,937
Closed
177
Calls
$2.65B
Puts
$2.11B
Net Calls
+$534M
Net Calls Change
-$67.5M
Name Holding Trade Value Shares
Change
Change in
Stake
CYG
1551
Clean Yield Group
Vermont
$3.2M -$25.4K -164 -0.7%
DAM
1552
Diamant Asset Management
Connecticut
$3.2M
BC
1553
Broadwater Capital
Massachusetts
$3.2M -$212K -1,365 -6%
CFGS
1554
Concourse Financial Group Securities
Alabama
$3.19M -$301K -1,940 -8%
SC
1555
Sawyer & Company
Massachusetts
$3.18M -$494K -3,189 -13%
EWM
1556
Evergreen Wealth Management
Michigan
$3.18M -$406K -2,623 -11%
BMC
1557
Beaton Management Company
Massachusetts
$3.17M -$32.1K -207 -0.9%
EFS
1558
Econ Financial Services
Pennsylvania
$3.17M +$1.76M +11,340 +107%
LCM
1559
Legato Capital Management
California
$3.17M -$552K -3,565 -14%
CCC
1560
Chelsea Counsel Company
California
$3.16M -$270K -1,744 -7%
TCMP
1561
Thrive Capital Management (Pennsylvania)
Pennsylvania
$3.16M +$893K +5,764 +36%
BKA
1562
Brick & Kyle Associates
Pennsylvania
$3.15M -$31.5K -203 -0.9%
GLA
1563
Good Life Advisors
Pennsylvania
$3.15M -$343K -2,211 -9%
SWM
1564
Scissortail Wealth Management
Oklahoma
$3.14M +$3.3M +21,320 +5,251%
AF
1565
Apexium Financial
Texas
$3.14M +$1.75M +11,262 +108%
CA
1566
Claro Advisors
Massachusetts
$3.13M -$513K -3,311 -13%
SLI
1567
Sumitomo Life Insurance
Japan
$3.12M -$71.1K -459 -2%
FTWA
1568
Fifth Third Wealth Advisors
Ohio
$3.12M +$279K +1,800 +9%
LA
1569
LVW Advisors
New York
$3.11M +$373K +2,406 +13%
SCA
1570
St. Clair Advisors
Ohio
$3.1M +$52.4K +338 +2%
EFM
1571
Eley Financial Management
Vermont
$3.1M +$186K +1,203 +6%
KLCM
1572
KG&L Capital Management
Louisiana
$3.09M -$36.9K -238 -1%
NAMP
1573
NorthStar Asset Management (Pennsylvania)
Pennsylvania
$3.09M -$23.2K -150 -0.7%
PGWM
1574
Pitti Group Wealth Management
New York
$3.09M -$90.8K -586 -3%
MBT
1575
Montecito Bank & Trust
California
$3.09M

JNJ Hedge Fund Activity: Q4 2024 in Review

4,108 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2024, worth a combined $257B — down 7.5% from $278B a quarter earlier.

Buyers outnumbered sellers: 471 funds opened new JNJ positions and 177 closed out — a net gain of 294 holders — while 1,352 added to existing stakes and 1,937 trimmed.

The largest buyer was Pinnacle Associates, adding an estimated $729M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.38B.

  • 4,108 institutional investors held Johnson & Johnson (JNJ) as of Q4 2024, up from 3,885 in Q3 2024.
  • Funds reported $257B of Johnson & Johnson stock for Q4 2024, down 7.5% quarter-over-quarter.
  • 471 funds opened new Johnson & Johnson positions in Q4 2024 and 177 closed out, a net change of +294 holders.
  • The largest Johnson & Johnson buyer in Q4 2024 was Pinnacle Associates, an estimated $729M added.
  • The largest Johnson & Johnson seller in Q4 2024 was T. Rowe Price Associates, an estimated $1.38B sold.

Based on aggregated 13F filings for Q4 2024.